News

Understanding ProVen Growth and Income VCT plc Voting Rights

Understanding ProVen Growth and Income VCT plc Voting Rights

ProVen Growth and Income VCT plc: Voting Rights Overview

ProVen Growth and Income VCT plc provides essential information regarding its total voting rights as part of its commitment to transparency. This update outlines the significant details as of September 30, 2025, ensuring shareholders are well-informed about their positions.

Capital and Voting Rights Breakdown

As dictated by the Disclosure and Transparency Rule, ProVen Growth and Income VCT plc reports that the company has 324,029,381 ordinary shares issued. Each of these shares carries one voting right, resulting in a total of 324,029,381 voting rights within the company.

Ordinary Shares Details

The ordinary shares of ProVen Growth and Income VCT plc are valued at 1.6187p each. Shareholders can leverage this information to gauge their influence in company decisions and maintain an active role in corporate governance.

Total Voting Rights Consolidation

The total voting rights, highlighted earlier, affirm the weight of shareholder opinions in the operational aspect of the company. With the current number of voting rights, shareholders are equipped to make necessary notifications as per FCA guidelines.

Company Treasury and Shareholdings

An important aspect to note is that ProVen Growth and Income VCT plc does not hold any treasury shares. This factor is significant because it underscores the full availability of voting rights among the current shareholders without dilution from treasury shares.

Impact of Recent Buybacks

The company maintains accuracy in its reporting by considering shares that have been repurchased for cancellation, even if such transactions are yet to settle. This information is crucial for shareholders as it affects the calculations for potential interest notifications.

Shareholder Responsibilities

Shareholders must use the total voting rights figure, which is 324,029,381, as a reference point to determine if they need to declare interest changes under the FCA's Disclosure and Transparency Rules. Being proactive in this matter is vital for compliance and maintaining good standing within the company.

Contact Information

For further inquiries or clarifications regarding voting rights or company information, shareholders can reach out to Beringea LLP, the company secretary, at the contact number provided: 020 7845 7820. Open communication helps to foster better understanding and engagement between the company and its shareholders.

Frequently Asked Questions

What are total voting rights in ProVen Growth and Income VCT plc?

Total voting rights refer to the number of shares that provide voting power to shareholders, which, in this case, is 324,029,381.

How can shareholders use the voting rights figure?

The voting rights figure serves as a basis for shareholders to determine if they need to notify changes in their interests related to the company.

Does ProVen Growth and Income VCT plc hold treasury shares?

No, the company does not hold any treasury shares, allowing for full transparency in voting rights.

What steps should a shareholder take if their interest changes?

Shareholders should refer to the total voting rights figure and notify the appropriate entities as per FCA requirements.

Who should shareholders contact for more information?

Shareholders can contact Beringea LLP at 020 7845 7820 for any inquiries about the company or its voting rights.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading

Top 5 Most Recently Viewed Articles

Successful Winddown: Stroock Law Firm Completes Its Journey

Updated Category News Views 186

Stroock & Stroock & Lavan LLP Completes Winddown Process In a significant development for the legal industry, the former law firm Stroock & Stroock & Lavan LLP has successfully concluded its dissolution process. The Liquidation Manager for the firm announced the completion of the out-of-court winddown, marking the end of an era that spanned nearly 150 years of legal...

Continue Reading
Realty Income: Reliable Dividends with Strong Growth Outlook

Updated Category News Views 129

Realty Income: A Leader in Monthly Dividends Realty Income (NYSE: O), popularly referred to as "The Monthly Dividend Company," stands out in the realm of Real Estate Investment Trusts (REITs). Specializing in free-standing properties, the company secures them through long-term net lease agreements. This unique approach sets Realty Income apart from many competitors....

Continue Reading
Ironwood Pharmaceuticals Rethinks Future and Rebounds Strongly

Updated Category News Views 121

The Shift in Ironwood Pharmaceuticals’ Financial Projection The pharmaceutical sector is well-known for its volatility, often swayed by the outcomes of clinical trials. In this environment, Ironwood Pharmaceuticals has made headlines not for its medical advancements but for its impressive financial guidance. This guidance signaled a significant change as investors saw...

Continue Reading
HSBC Considers Merging Banking Divisions for Efficiency Gains

Updated Category News Views 64

HSBC's Strategic Move: Merging Commercial and Investment Banking HSBC is currently considering a major operational restructure that may involve merging its Commercial and Investment banking divisions. This strategic initiative aims to reduce redundancy and enhance efficiency, showcasing the bank's ongoing commitment to effective cost management and operational excellence....

Continue Reading
Natural Remedies for Herpes Outbreaks Amid Market Growth

Updated Category News Views 376

Natural Remedies for Herpes Outbreaks In recent years, there has been an increasing interest in natural remedies to manage herpes outbreaks. As consumer awareness around health continues to evolve, the market for dietary supplements has expanded significantly, reaching a notable $1.23 billion. Amidst this backdrop, Herpafend has emerged as a key player, offering a unique...

Continue Reading